EMBARGOED FOR RELEASE UNTIL 4 PM ET, March 11, 2002
St. Paul, Minn. – Eye pain is an oft-accompanied symptom of migraine sufferers. Researchers have found that treating inflammation in the eye''''s trochlea tendon can relieve the headache pain associated with migraines, or prevent the triggering of full-blown migraine attacks. The study of five migraine patients with trochleitis (inflammation of the trochlea tendon) is reported in the March 12 issue of Neurology, the scientific journal of the American Academy of Neurology. Participants in the study included five women who suffered from migraine following the onset of pain around the area of the eye socket, and which through a battery of tests including brain imaging, were determined to have trochleitis. The women reported the onset of trochleitis caused their baseline migraine headache to worsen for several hours, or even days. The women had suffered from trochleitis from two to 18 years, and described a range of pain from "dull ache" to "excruciating." Patients were treated with steroid injections of dexamethasone and methylprednisolone applied directly to the inflamed trochlea. Injections produced relief of the ocular pain and associated migraine symptoms within 48 to 72 hours. "Other types of headaches with an eye pain component should be considered for investigation into the effectiveness of steroid treatment," said Rodilla. The study was supported in part by the PPA Humphrey -IHS- GlaxoSmithKline 2000 Research Fellowship (M Sanchez del Rio).
The American Academy of Neurology is the world's largest association of neurologists and neuroscience professionals, with 34,000 members. The AAN is dedicated to promoting the highest quality patient-centered neurologic care. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as Alzheimer's disease, stroke, migraine, multiple sclerosis, concussion, Parkinson's disease and epilepsy.